Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 3/20 | 0.52 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.48 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.44 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.44 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | PGK1 | P00558 | 1/20 | 0.42 |
| ▸ | PGK2 | P07205 | 1/20 | 0.42 |
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11564452 | 0.97 | KCNH2 (0.50) | KCNH2CXCR4HRH4GRIN2DGRIN3B | |
| SCHEMBL660573 | 0.87 | KCNH2 (0.43) | KCNH2CXCR4HRH4GRIN2DGRIN3B | |
| SCHEMBL2096973 | 0.87 | KCNH2 (0.43) | KCNH2CXCR4HRH4GRIN2DGRIN3B | |
| SCHEMBL3709903 | 0.87 | KCNH2 (0.43) | KCNH2CXCR4HRH4GRIN2DGRIN3B | |
| SCHEMBL5104176 | 0.87 | CCR1 (0.44) | KCNH2CXCR4HRH4GRIN2DGRIN3B | |
| SCHEMBL7685870 | 0.87 | KCNH2 (0.59) | KCNH2CXCR4HRH4GRIN2DGRIN3B | |
| SCHEMBL15223507 | 0.87 | KCNH2 (0.43) | KCNH2CXCR4HRH4GRIN2DGRIN3B | |
| SCHEMBL12242755 | 0.87 | KCNH2 (0.43) | KCNH2CXCR4HRH4GRIN2DGRIN3B | |
| SCHEMBL4046726 | 0.87 | KCNH2 (0.48) | KCNH2CXCR4HRH4GRIN2DGRIN3B | |
| SCHEMBL244011 | 0.86 | CCR1 (0.46) | KCNH2CXCR4HRH4GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 388 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119143751-A | N-ortho-acyl substituted nitrogen-containing heterocyclic compound and preparation method of amine-shrinking iron (II) complex thereof | 中国石油化工股份有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-113754694-A | Method for synthesizing Reidesvir by asymmetric catalysis of non-protecting group nucleoside | 上海交通大学 | 2021-12-07 | — | — | CN | claimed |
| CN-107011133-B | Method for directly oxidizing benzylic C-H bond into ketone | 中国科学技术大学 | 2020-01-03 | — | — | CN | claimed |
| US-9796800-B2 | Process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2017-10-24 | — | — | US | claimed |
| US-20160108153-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2016-04-21 | — | — | US | claimed |
| US-9266982-B2 | N ortho acyl substituted nitrogen-containing heterocyclic compound and process for preparing aminal iron (II) complexes thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2016-02-23 | — | — | US | claimed |
| US-9249244-B2 | Process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2016-02-02 | — | — | US | claimed |
| US-20130267708-A1 | N ORTHO ACYL SUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND PROCESS FOR PREPARING AMINAL IRON (II) COMPLEXES THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2013-10-10 | — | — | US | claimed |
| EP-2619233-A1 | PROCESS FOR PRODUCING POLYDIENES | Bridgestone Corporation (JP) | 2013-07-31 | — | — | EP | claimed |
| WO-2012040026-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2012-03-29 | — | — | WO | claimed |
| WO-2006136695-A2 | NOVEL P-CHIRAL FUNCTIONALISED ARYLPHOSPHINES AND DERIVATIVES, THE PREPARATION AND USE THEREOF FOR ASYMMETRICAL CATALYSIS | PHOSPHOENIX SARL (FR) | 2006-12-28 | — | — | WO | claimed |
| WO-2006021304-A1 | METHOD FOR HIGH-PURITY QUATERNARY AMMONIUM COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-02 | — | — | WO | claimed |
| WO-2006021302-A1 | METHOD FOR PRODUCING HIGH-PURITY QUATERNARY AMMONIUM COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-02 | — | — | WO | claimed |
| US-20020147331-A1 | Methods for synthesis of oligonucleotides | ISIS PHARMACEUTICALS, INC. | 2002-10-10 | — | — | US | claimed |
| WO-2002062811-A2 | IMPROVED METHODS FOR SYNTHESIS OF OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 2002-08-15 | — | — | WO | claimed |
| EP-0729985-A2 | Ethylene-propylene copolymer compositions | SHELL OIL COMPANY (US) | 1996-09-04 | — | — | EP | claimed |
| US-5495009-A | TREATING WITH BROMINE IN PRESENCE OF 2,6-DIETHYLPYRIDINE AND MOLECULAR SIEVES FOLLOWED BY TREATMENT WITH TETRABUTYLAMMONIUM FLUORIDE IN TETRAHYDROFURAN | GILEAD SCIENCES, INC. (US) | 1996-02-27 | — | — | US | claimed |
| US-5229477-A | Randomness | SHELL OIL COMPANY (US) | 1993-07-20 | — | — | US | claimed |
| WO-1992019637-A1 | OLIGONUCLEOTIDE ANALOGS CONTAINING THIOFORMACETAL LINKAGES | GILEAD SCIENCES, INC. (US) | 1992-11-12 | — | — | WO | claimed |
| EP-0493070-A2 | Ethylene-propylene copolymer compositions | SHELL OIL COMPANY (US) | 1992-07-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020147331-A1 | Methods for synthesis of oligonucleotides | RNGTT, TYMP, PNP | KCNH2 4292/4885CXCR4 1353/4885HRH4 4470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.